课题基金 / 基金详情

THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA

THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
高剂量辛伐他汀对原发性高胆固醇血症的影响
批准号：
6116953
负责人：
D ROGER ILLINGWORTH
金额：
$3.13万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6116953
关键词：
antihypercholesterolemic agent clinical research dosage drug screening /evaluation familial hyperlipoproteinemia type II human subject human therapy evaluation lovastatin metabolism disorder chemotherapy

项目摘要

项目成果

D ROGER ILLINGWORTH的其他基金

相似基金

相关文献

中文摘要
翻译
本研究将比较其对降血脂的作用、影响
英文摘要
This study will compare the hypolipidemic effects, influence on lipoprotein and cholesterol metabolism on gemfibrozil, simvastatin and atorvastatin in patients with type III hyperlipidemia. After a 4 week dietary baseline, patients will be treated in a random sequence with gemfibrozil, simvastatin or atorvastatin each for 8 weeks; efficacy, metabolic effects and safety will be evaluated on each regimen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of simvastatin on postprandial hyperlipidemia
REGULAR AND SUSTAINED RELEASE SIMVISTATIN IN HYPERCHOLESTEROLEMIA
SIMVASTATIN ON STEROID HORMONE PRODUCTION IN MEN WITH HYPERCHOLESTEROLEMIA
METABOLIC STUDY ON THE HYPOLIPIDEMIC EFFECTS OF DRUGS WHICH INHIBIT CHOLESTEROL
海外基金